We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Alliance Pharma Plc | LSE:APH | London | Ordinary Share | GB0031030819 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.05 | -0.14% | 34.85 | 34.80 | 35.05 | 35.75 | 34.85 | 35.75 | 85,834 | 11:19:57 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 167.42M | 936k | 0.0017 | 205.00 | 188.24M |
From Apr 2019 to Apr 2024
TIDMAPH
RNS Number : 1206A
Alliance Pharma PLC
22 December 2017
ALLIANCE PHARMA PLC
("Alliance" or the "Group")
Block Listing Six Monthly Return
Hot Features
Premium
Name of applicant: ALLIANCE PHARMA PLC
----------------------------------------------------- ---------------------------------------------------------------
Names of schemes: a) The Alliance Pharma plc Approved Share Option Plan 2005
b) The Alliance Pharma plc Share Option Plan 2006
c) The Alliance Pharma plc Company Share Option Plan 2015
----------------------------------------------------- ---------------------------------------------------------------
Period of return: From: 28 June 2017 To: 28 December 2017
----------------------------- ---------------------- ----------------------- ------- -----------------------------
Number of securities originally admitted at date of 25,000,000 ordinary shares of 1p each
admission: 28 June 2017
----------------------------------------------------- ---------------------------------------------------------------
Balance of unallotted securities under schemes from a) 2,248,922
previous return: b) 19,461,225
c) 3,289,853
----------------------------------------------------- ---------------------------------------------------------------
Plus: The amount by which the block schemes have a) Nil
been increased since the date of the last b) Nil
return (if any increase has been applied for): c) Nil
----------------------------------------------------- ---------------------------------------------------------------
Less: Number of securities issued/allotted under a) 326,427
schemes during period: b) 355,982
c) Nil
----------------------------------------------------- ---------------------------------------------------------------
Equals: Balance under schemes not yet a) 1,922,495
issued/allotted at end of period: b) 19,105,243
c) 3,289,853
----------------------------------------------------- ---------------------------------------------------------------
Name of contact: Marie-Claire Haines, Assistant Company Secretary
----------------------------- -------------------------------------------------
Telephone number of contact: Tel. +44 (0)1249 705166
----------------------------- -------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRUAOSRBNAUUAA
(END) Dow Jones Newswires
December 22, 2017 02:00 ET (07:00 GMT)
1 Year Alliance Pharma Chart |
1 Month Alliance Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
